Expanded Access Program (EAP)

Expanded access (compassionate use) is a programme in the United States that allows limited access to drugs which are not FDA approved for any condition.

Ampligen
Ampiglen (rintatolimod) is a drug used by some ME/CFS patients through expanded access.